# Corneal Endothelial Cell Density in Eyes Treated With a Fluocinolone Acetonide Intravitreal Implant

> **NCT03145025** · — · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 3 (actual)

## Conditions studied

- Uveitis, Posterior

## Interventions

- **DEVICE:** Retisert
- **DRUG:** Fluocinolone Acetonide Intravitreal Implant

## Key facts

- **NCT ID:** NCT03145025
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-14
- **Primary completion:** 2018-09-10
- **Final completion:** 2019-03-22
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2019-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03145025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03145025, "Corneal Endothelial Cell Density in Eyes Treated With a Fluocinolone Acetonide Intravitreal Implant". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03145025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*